Table 1

Descriptive variables of 73 892 participants in AusVaxSafety’s 2017 influenza vaccine safety surveillance

VariableDescriptionn (%)
Sex* Male30 968 (41.9)
Female42 869 (58.1)
Indigenous status Aboriginal1000 (1.7)
Torres Strait Islander32 (0.1)
Both124 (0.2)
Total1156 (2.0)
Pregnant 2018 (2.8)
Age median (IQR; range)57 years (31–69 years; 6 months to 102 years)
Age group6 months to 4 years6180 (8.4)
5–14 years4415 (6.0)
15–39 years13 434 (18.2)
40–64 years21 709 (29.4)
≥65 years28 154 (38.1)
Number of participants receiving concomitant vaccine(s)10 428 (14.1)
Most common concomitant vaccines by group§¶
Overall
(n=10 428)
23vPPV2756 (26.4)
dTpa/dTpa-IPV2504 (24.0)
Zoster1708 (16.4)
6 months to 4 years
(n=1295)
DTPa-IPV268 (20.7)
HibMenCCV+MMR235 (18.1)
MenBV206 (15.9)
DTPa+MMRV205 (15.8)
5–14 years
(n=295)
HPV46 (15.6)
Typhoid+hepatitis A43 (14.6)
Hepatitis A39 (13.2)
MenBV34 (11.5)
15–39 years
(n=2612)
dTpa/dTpa-IPV1743 (66.7)
Typhoid-hepatitis A94 (3.6)
Hepatitis A85 (3.3)
40–64 years
(n=1516)
dTpa/dTpa-IPV534 (35.2)
23vPPV311 (20.5)
Typhoid87 (5.7)
≥65 years
(n=4710)
23vPPV2403 (51.0)
Zoster1699 (36.1)
dTpa/dTpa-IPV220 (4.7)
Pregnant**
(n=634)
dTpa/dTpa-IPV633 (99.8)
dTpa/dTpa-IPV+hepatitis B1 (0.2)
  • *Sex available for n=73 837 participants.

  • †Indigenous status available for n=58 145 participants.

  • ‡Pregnancy status available for n=72 951 participants (SmartVax only).

  • §The percentages listed under ‘concomitant vaccines’ are the percentage of all concomitant vaccine(s) administered per group.

  • ¶+ indicates two separate vaccines administered concomitantly.

  • **Pregnant participants are also included in their respective age categories (age range: 15–49 years).

  • 23vPPV, 23-valent pneumococcal polysaccharide vaccine; DTPa,  Diphtheria tetanus acellular pertussis (for children aged <10 years); DTPa-IPV, DTPa-inactivated polio vaccine (for children aged <10 years); dTpa, diphtheria tetanus acellular pertussis (for individuals aged ≥10 years); dTpa-IPV, dTpa-inactivated polio vaccine (for individuals aged ≥10 years); HibMenCCV, Haemophilus influenzae type B meningococcal C conjugate vaccine; HPV, human papillomavirus; MenBV, meningococcal B vaccine; MMR, measles, mumps and rubella; MMRV, measles, mumps, rubella and varicella.